Select your preferred language.

Choisissez votre langue préférée

Thursday, October 24, 2019

MyBayer Shutting Down, but Retailers Can Access a Wealth of Online Tools in the Dealer Access Portal

We’ve streamlined our retailers’ online platform. The Dealer Access Portal replaces MyBayer and provides retailers with the tools they need for seed bookings and more.

Calgary, Alberta – October 24th, 2019 - Today we are announcing the retirement of the MyBayer Portal. Retailers will continue to be able to access a wealth of great online tools from a single streamlined experience with the Dealer Access Portal. Moving forward this will serve as our primary online point of contact for our retail partners.

Our Dealer Access Portal contains a number of great features, all conveniently located in one place. The portal allows retailers to perform some of the following functions:

  • Incredible Bayer Offer sign ups (Available Dec. 2020)
  • Direct-to-grower sales reports for corn, canola and soybean seed
  • Grower TSA number lookup
  • Payment backup review
  • Access to program guides
  • Bayer's Integrated Portfolio Planning Tool
  • Roundup Product Training

If you don’t have access to the Dealer Access Portal, please reach out to our technical support line at 1-800-667-4944.

Keep an eye on the Dealer Access Portal for new and expanded features coming soon!

Click to access the dealer login portal.

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, visit